News | February 18, 2023
Asahi Kasei completes construction of microcrystalline cellulose plant
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
The newly launched centre in Mumbai is part of the company’s ambition to be present in 100 cities across the country within two years.”
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
This drug candidate, which is currently progressing through pivotal clinical studies, has the potential to become the first add-on therapy for schizophrenia patients who do not respond adequately
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
Subscribe To Our Newsletter & Stay Updated
